283 related articles for article (PubMed ID: 30451482)
1. Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy.
Shi Y; Li J; Zhang Z; Duan D; Zhang Z; Liu H; Liu T; Liu Z
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43387-43395. PubMed ID: 30451482
[TBL] [Abstract][Full Text] [Related]
2. A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.
Li J; Shi Y; Zhang Z; Liu H; Lang L; Liu T; Chen X; Liu Z
Bioconjug Chem; 2019 Nov; 30(11):2870-2878. PubMed ID: 31593447
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
[TBL] [Abstract][Full Text] [Related]
6. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
[TBL] [Abstract][Full Text] [Related]
7. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects.
Gao Z; Horiguchi Y; Nakai K; Matsumura A; Suzuki M; Ono K; Nagasaki Y
Biomaterials; 2016 Oct; 104():201-12. PubMed ID: 27467416
[TBL] [Abstract][Full Text] [Related]
8. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
9. Covalent Organic Polymer as a Carborane Carrier for Imaging-Facilitated Boron Neutron Capture Therapy.
Shi Y; Fu Q; Li J; Liu H; Zhang Z; Liu T; Liu Z
ACS Appl Mater Interfaces; 2020 Dec; 12(50):55564-55573. PubMed ID: 33327054
[TBL] [Abstract][Full Text] [Related]
10. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
[TBL] [Abstract][Full Text] [Related]
11. Boronated compounds for imaging guided BNCT applications.
Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
Takeuchi I; Nomura K; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
[TBL] [Abstract][Full Text] [Related]
13. On-Demand Biodegradable Boron Nitride Nanoparticles for Treating Triple Negative Breast Cancer with Boron Neutron Capture Therapy.
Li L; Li J; Shi Y; Du P; Zhang Z; Liu T; Zhang R; Liu Z
ACS Nano; 2019 Dec; 13(12):13843-13852. PubMed ID: 31697475
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice.
Miura M; Morris GM; Micca PL; Nawrocky MM; Makar MS; Cook SP; Slatkin DN
Br J Radiol; 2004 Jul; 77(919):573-80. PubMed ID: 15238404
[TBL] [Abstract][Full Text] [Related]
16. A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma.
Xiang J; Ma L; Gu Z; Jin H; Zhai H; Tong J; Liang T; Li J; Ren Q; Liu Q
Cells; 2022 Mar; 11(7):. PubMed ID: 35406737
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
[TBL] [Abstract][Full Text] [Related]
19. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1825-32. PubMed ID: 9717808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
